Overview Dividends

(SNPS) Synopsys - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8716071076

EDA Software, Verification Tools, IP Cores, FPGA

Application Software
Market Cap in USD: 90,952m

IPO / Inception: 1992-02-26
Return 12m vs S&P 500: -20.7%

EPS (Earnings per Share)

EPS CAGR: 5.18%
EPS Trend: 73.9%

Last SUE: 0.62
Qual. Beats: 0

Revenue

Rev. CAGR: 16.52%
Rev. Trend: 87.0%

Last SUE: 0.06
Qual. Beats: 0

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	37.9%
Value at Risk 5%th	56.3%
Relative Tail Risk	-9.71%

Reward TTM
Sharpe Ratio	0.04
Alpha	-28.19
CAGR/Max DD	0.31

Character TTM
Hurst Exponent	0.599
Beta	1.358
Beta Downside	1.373

Drawdowns 3y
Max DD	40.53%
Mean DD	11.68%
Median DD	7.47%

Description: SNPS Synopsys December 02, 2025

Synopsys Inc. (NASDAQ: SNPS) delivers electronic design automation (EDA) software that enables the design, verification, and testing of integrated circuits, operating through two primary segments: Design Automation and Design IP. Its portfolio spans digital and custom IC design tools, verification suites (including virtual prototyping, static/formal verification, simulation, emulation, and FPGA-based prototyping), TCAD and mask synthesis, as well as AI-enhanced EDA solutions. The company also licenses a broad suite of IP blocks-ranging from UCIe, USB, PCI Express, DDR, Ethernet, MIPI, HDMI, and automotive-grade security IP to processor cores, embedded memories, and Arm AMBA interconnects-supporting system-on-chip (SoC) development across diverse markets.

Key recent metrics underscore Synopsys’ market position: FY 2024 revenue reached approximately $5.6 billion, with a GAAP earnings-per-share of about $5.00, and R&D expenditures representing roughly 30 % of revenue-reflecting its commitment to innovation in advanced-node design and AI-driven verification. The company benefits from the broader semiconductor cycle, where rising demand for high-performance compute, automotive electronics, and 5G infrastructure fuels growth in EDA spend, while its expanding AI-EDA offerings address the industry’s need for faster time-to-market on increasingly complex chips.

For a deeper quantitative view, consider exploring ValueRay’s analyst toolkit to complement your assessment of Synopsys’ valuation and growth outlook.

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (1.33b TTM) > 0 and > 6% of Revenue (6% = 423.2m TTM)

FCFTA 0.03 (>2.0%) and ΔFCFTA -4.94pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 32.46% (prev 62.37%; Δ -29.91pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.03 (>3.0%) and CFO 1.44b > Net Income 1.33b (YES >=105%, WARN >=100%)

Net Debt (11.41b) to EBITDA (2.62b) ratio: 4.36 <= 3.0 (WARN <= 3.5)

Current Ratio 1.62 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (161.7m) change vs 12m ago 3.65% (target <= -2.0% for YES)

Gross Margin 73.06% (prev 76.61%; Δ -3.55pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 23.02% (prev 46.85%; Δ -23.83pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 4.13 (EBITDA TTM 2.62b / Interest Expense TTM 445.4m) >= 6 (WARN >= 3)

Altman Z'' 1.94

(A) 0.05 = (Total Current Assets 6.01b - Total Current Liabilities 3.72b) / Total Assets 48.22b

(B) 0.21 = Retained Earnings (Balance) 10.32b / Total Assets 48.22b

(D) 0.51 = Book Value of Equity 10.08b / Total Liabilities 19.90b

Total Rating: 1.94 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 60.24

1. Piotroski 3.0pt

2. FCF Yield 1.27%

3. FCF Margin 18.46%

4. Debt/Equity 0.50

5. Debt/Ebitda 4.36

6. ROIC - WACC (= -2.96)%

7. RoE 7.09%

8. Rev. Trend 87.01%

9. EPS Trend 73.93%

What is the price of SNPS shares?

As of December 19, 2025, the stock is trading at USD 458.13 with a total of 1,694,339 shares traded.
Over the past week, the price has changed by -4.01%, over one month by +19.36%, over three months by -4.58% and over the past year by -7.34%.

Is SNPS a buy, sell or hold?

Synopsys has received a consensus analysts rating of 4.55. Therefore, it is recommended to buy SNPS.

Strong Buy: 15
Buy: 4
Hold: 3
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the SNPS price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	546.5	19.3%
Analysts Target Price	546.5	19.3%
ValueRay Target Price	475.3	3.8%

SNPS Fundamental Data Overview December 13, 2025

Market Cap USD = 90.95b (90.95b USD * 1.0 USD.USD)
P/E Trailing = 58.9938
P/E Forward = 32.1543
P/S = 12.8933
P/B = 3.2837
P/EG = 6.2392
Beta = 1.154
Revenue TTM = 7.05b USD
EBIT TTM = 1.84b USD
EBITDA TTM = 2.62b USD
Long Term Debt = 14.32b USD (from longTermDebt, two quarters ago)
Short Term Debt = 150.3m USD (from shortTermDebt, last quarter)
Debt = 14.29b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.41b USD (from netDebt column, last quarter)
Enterprise Value = 102.28b USD (90.95b + Debt 14.29b - CCE 2.96b)
Interest Coverage Ratio = 4.13 (Ebit TTM 1.84b / Interest Expense TTM 445.4m)
FCF Yield = 1.27% (FCF TTM 1.30b / Enterprise Value 102.28b)
FCF Margin = 18.46% (FCF TTM 1.30b / Revenue TTM 7.05b)
Net Margin = 18.88% (Net Income TTM 1.33b / Revenue TTM 7.05b)
Gross Margin = 73.06% ((Revenue TTM 7.05b - Cost of Revenue TTM 1.90b) / Revenue TTM)
Gross Margin QoQ = 60.45% (prev 78.13%)
Tobins Q-Ratio = 2.12 (Enterprise Value 102.28b / Total Assets 48.22b)
Interest Expense / Debt = 1.36% (Interest Expense 194.8m / Debt 14.29b)
Taxrate = 13.18% (68.1m / 516.5m)
NOPAT = 1.60b (EBIT 1.84b * (1 - 13.18%))
Current Ratio = 1.62 (Total Current Assets 6.01b / Total Current Liabilities 3.72b)
Debt / Equity = 0.50 (Debt 14.29b / totalStockholderEquity, last quarter 28.33b)
Debt / EBITDA = 4.36 (Net Debt 11.41b / EBITDA 2.62b)
Debt / FCF = 8.76 (Net Debt 11.41b / FCF TTM 1.30b)
Total Stockholder Equity = 18.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.76% (Net Income 1.33b / Total Assets 48.22b)
RoE = 7.09% (Net Income TTM 1.33b / Total Stockholder Equity 18.79b)
RoCE = 5.56% (EBIT 1.84b / Capital Employed (Equity 18.79b + L.T.Debt 14.32b))
RoIC = 6.73% (NOPAT 1.60b / Invested Capital 23.75b)
WACC = 9.68% (E(90.95b)/V(105.25b) * Re(11.02%) + D(14.29b)/V(105.25b) * Rd(1.36%) * (1-Tc(0.13)))
Discount Rate = 11.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.18%
[DCF Debug] Terminal Value 67.73% ; FCFE base≈1.18b ; Y1≈1.15b ; Y5≈1.17b
Fair Price DCF = 69.04 (DCF Value 13.16b / Shares Outstanding 190.6m; 5y FCF grow -3.26% → 3.0% )
EPS Correlation: 73.93 | EPS CAGR: 5.18% | SUE: 0.62 | # QB: 0
Revenue Correlation: 87.01 | Revenue CAGR: 16.52% | SUE: 0.06 | # QB: 0
EPS next Quarter (2026-01-31): EPS=3.55 | Chg30d=+0.126 | Revisions Net=+0 | Analysts=9
EPS current Year (2026-10-31): EPS=14.39 | Chg30d=+0.306 | Revisions Net=-4 | Growth EPS=+11.5% | Growth Revenue=+36.3%
EPS next Year (2027-10-31): EPS=17.28 | Chg30d=-0.110 | Revisions Net=+1 | Growth EPS=+20.1% | Growth Revenue=+10.9%

Additional Sources for SNPS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle